SSA
FMI

Schonfeld Strategic Advisors’s Foundation Medicine, Inc. FMI Stock Holding History

Schonfeld Strategic Advisors’s Portfolio FMI Stock Details FMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-22,512
Closed -$1.77M – 1094
2018
Q1 		$1.77M Buy
22,512
+5,207
+30% +$384K 0.13% 220
2017
Q4 		$1.18M Buy
+17,305
New +$897K 0.1% 274

Other funds holding FMI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

Schonfeld Strategic Advisors's FMI Position: Q2 2018 in Review

Schonfeld Strategic Advisors sold out of Foundation Medicine, Inc. (FMI) in Q2 2018, closing a stake of 22,512 shares — an estimated $1.77M sold.

Schonfeld Strategic Advisors first reported a position in FMI in Q4 2017 and held it in 2 quarters. The position peaked at $1.77M in Q1 2018. 157 funds tracked by Wall St. Rank hold FMI as of Q2 2018.

  • Schonfeld Strategic Advisors reported no remaining Foundation Medicine, Inc. position as of Q2 2018 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 22,512 Foundation Medicine, Inc. shares in Q2 2018, an estimated $1.77M.
  • Schonfeld Strategic Advisors first reported a position in Foundation Medicine, Inc. in Q4 2017 and held it in 2 quarters.
  • Schonfeld Strategic Advisors's Foundation Medicine, Inc. position peaked at $1.77M in Q1 2018.
  • 157 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q2 2018.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.